| Dr Houshang Semino, MD | |
|
17215 N 72nd Dr, D-140a, Glendale, AZ 85308-8558 | |
| (623) 487-9630 | |
| (623) 487-9631 |
| Full Name | Dr Houshang Semino |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 17215 N 72nd Dr, Glendale, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154388650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 10751 (Arizona) | Primary |
| Entity Name | Southwest Behavioral Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144384389 PECOS PAC ID: 9739075854 Enrollment ID: O20040225000948 |
News Archive
The drug, ladostigil, is a molecule that combines components from the existing drugs Azilect and Exelon. Teva's Azilect, for the treatment of Parkinson's disease, was developed by Prof. Emeritus Moussa Youdim of the Technion-Israel Institute of Technology. Azilect is the only anti-Parkinson's drug that has proven to have a disease-modifying effect. Novartis's Exelon was developed by Prof. Marta Weinstock-Rosin of Hebrew University to treat Alzheimer's disease.
Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial effects of romosozumab, an antibody therapy that targets sclerostin, on bone tissue in postmenopausal women with osteoporosis.
"DNA damage is associated with cancer risk. Sources of DNA damage include diet-related carcinogens, and bodily processes like oxidative stress – and the raw sprouts protect against this kind of damage.
Microsulis reports that the groundbreaking Accu2i pMTA system for destroying unwanted tissue and used in the treatment of liver and other cancers now carries an impressive range of electrical safety standards. The Accu2i is CE-marked and carries FDA 510(k) clearance and so is cleared for electrical safety and performance with the internationally recognised standard IEC 60601-1 for electrical safety.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Houshang Semino, MD 11638 N 12th Pl, Phoenix, AZ 85020-1221 Ph: (602) 390-2496 | Dr Houshang Semino, MD 17215 N 72nd Dr, D-140a, Glendale, AZ 85308-8558 Ph: (623) 487-9630 |
News Archive
The drug, ladostigil, is a molecule that combines components from the existing drugs Azilect and Exelon. Teva's Azilect, for the treatment of Parkinson's disease, was developed by Prof. Emeritus Moussa Youdim of the Technion-Israel Institute of Technology. Azilect is the only anti-Parkinson's drug that has proven to have a disease-modifying effect. Novartis's Exelon was developed by Prof. Marta Weinstock-Rosin of Hebrew University to treat Alzheimer's disease.
Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial effects of romosozumab, an antibody therapy that targets sclerostin, on bone tissue in postmenopausal women with osteoporosis.
"DNA damage is associated with cancer risk. Sources of DNA damage include diet-related carcinogens, and bodily processes like oxidative stress – and the raw sprouts protect against this kind of damage.
Microsulis reports that the groundbreaking Accu2i pMTA system for destroying unwanted tissue and used in the treatment of liver and other cancers now carries an impressive range of electrical safety standards. The Accu2i is CE-marked and carries FDA 510(k) clearance and so is cleared for electrical safety and performance with the internationally recognised standard IEC 60601-1 for electrical safety.
› Verified 3 days ago
Thomas John Knutson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 11851 N 51st Ave, Glendale, AZ 85304 Phone: 480-882-4545 Fax: 480-882-5814 | |
Dr. Leticia G Jacinto, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 17100 N 67th Ave, Ste 401, Glendale, AZ 85308 Phone: 602-795-8698 Fax: 602-795-8699 | |
James Earnest Campbell, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4747 W Country Gables Dr., Glendale, AZ 85306 Phone: 602-439-2400 Fax: 602-439-1414 | |
Dr. Carl R Sonder, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18301 N 79th Ave, Ste C126, Glendale, AZ 85308 Phone: 623-486-3346 Fax: 623-486-3747 | |
Frederick Chapman Green Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8802 N 61st Ave, Glendale, AZ 85302 Phone: 623-934-1991 Fax: 480-733-3031 | |
Dr. Valerie Leah Sharf, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18701 N 67th Ave, Glendale, AZ 85308 Phone: 623-561-1000 |